Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELUGOLIX for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 18,752 adverse event reports in the FDA FAERS database where RELUGOLIX was used for Prostate cancer.

Most Reported Side Effects for RELUGOLIX

Side Effect Reports % Deaths Hosp.
Hot flush 6,845 33.1% 22 313
Fatigue 5,203 25.2% 44 297
Therapy interrupted 3,251 15.7% 20 99
Incorrect dose administered 1,917 9.3% 39 204
Asthenia 1,718 8.3% 25 182
Arthralgia 1,385 6.7% 6 93
Diarrhoea 1,383 6.7% 11 107
Product dose omission issue 1,189 5.8% 16 155
Dizziness 1,146 5.6% 10 105
Constipation 902 4.4% 9 84
Death 832 4.0% 832 74
Weight increased 805 3.9% 3 42
Insomnia 764 3.7% 3 60
Pain 750 3.6% 13 101
Myalgia 721 3.5% 5 44

Other Indications for RELUGOLIX

Product used for unknown indication (1,417) Uterine leiomyoma (115) Neoplasm malignant (65) Prostate cancer metastatic (42) Heavy menstrual bleeding (32) Endometriosis (23) Prostatic specific antigen increased (15) Adenomyosis (14) Hormone-refractory prostate cancer (13) Anaemia (10)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627) DOCETAXEL (1,551)

Related Pages

RELUGOLIX Full Profile All Prostate cancer Drugs RELUGOLIX Demographics RELUGOLIX Timeline